Vifor Pharma Deutschland secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient iron parenteral preparations ATC B03AC01 f d Z 011125-311027 plus extension option 1x12 months

Germany, June 1 -- Germany based Vifor Pharma Deutschland has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient iron parenteral preparations ATC B03AC01 f d Z 011125-311027 plus extension option 1x12 months . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....